Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 312 results.

Selected filters: Technologists

Displaying 111 to 120 of 312 records
Sort by: Page: << Prev 9… 10… 11… 12… 13… 14… 15… Next >>

Amino Acid PET Successfully Differentiates Recurrent Brain Metastases, Reducing Invasive Procedures and Overtreatment – May 12, 2023
A new meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes, potentially reducing overtreatment, according to research published in May JNM.
New Research: FAPI PET Imaging Superior for Diagnosing Multiple Types of Cancer, with Potential for Targeted Treatment – May 1, 2023
Two articles in the May issue of JNM illustrate the promise of the novel FAPI radiotracer. Results from the largest study of patients undergoing 68Ga-FAPI PET demonstrate the superiority of 68Ga-FAPI over standard 18F-FDG PET in evaluating multiple types of cancer. In a separate study, a newly designed FAPI-targeted treatment was found to suppress tumor growth in several common cancers in a preclinical setting. These advances have strong potential to provide more precise staging and management for cancer patients.
Novartis Announces FDA Approval for New Jersey Facility to Produce Pluvicto for Commercial Use – Apr 21, 2023
Today Novartis announced that it has received FDA approval to supply Pluvicto from its plant in Millburn, New Jersey. The company is planning to ramp up production in the coming weeks.
SNMMI Celebrates National Volunteer Week – Apr 20, 2023
A special thank you to all our members who volunteer their time, talent, and expertise to meet the critical needs of the nuclear medicine and molecular imaging community.
Newly Developed PSG Score Improves Patient Selection for PSMA Radiopharmaceutical Therapy – Apr 19, 2023
International, multicenter testing demonstrated the effectiveness of a newly established PSMA PET scoring system that can successfully predict whether metastatic castration-resistant prostate cancer patients will respond to treatment with Lu-177 PSMA therapy. The research was published online in JNM.
JNM Publishes Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema – Apr 14, 2023
SNMMI and 10 other professional societies have issued appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema. The criteria are summarized in the April issue of JNM.
New Nuclear Medicine Therapy Cures Human Non-Hodgkin Lymphoma in Preclinical Model – Apr 11, 2023
A single dose of the radioimmunotherapy can cure human non-Hodgkin lymphoma in an animal model, according to research published in the April issue of The Journal of Nuclear Medicine.
Blood-Based Biomarkers Accurately Predict Neuroendocrine Tumor Response to Radiopharmaceutical Therapy – Apr 6, 2023
A simple blood draw can provide physicians with valuable information about whether PRRT is likely to be effective in a patient with neuroendocrine canceropening new possibilities for tailoring radiopharmaceutical treatment to patients. The research is published in the April issue of JNM.
Molecular Imaging Offers Insight Into Chemo-Brain – Mar 28, 2023
A new literature review sheds light on how nuclear medicine brain imaging can help evaluate the biological changes that cause chemotherapy-related cognitive impairment (CRCI), commonly known as chemo-brain. This informationpublished ahead-of-print in JNMcan help patients better understand the changes in their cognitive status during and after treatment.
JNM Explores Potential Applications for ChatGPT in Nuclear Medicine and Molecular Imaging – Mar 27, 2023
In a new JNM article, Irne Buvat, PhD, and Wolfgang Weber, MD, PhD, explore the potential for using AI chatbot ChatGPT in the field of nuclear medicine and molecular imaging.

Displaying 111 to 120 of 312 records
Page: << Prev 9… 10… 11… 12… 13… 14… 15… Next >>